Taking everything into account, TEM scores 3 out of 10 in our fundamental rating. TEM was compared to 57 industry peers in the Life Sciences Tools & Services industry. TEM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TEM is valued quite expensive, but it does show an excellent growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.94% | ||
| ROE | -40.15% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.73% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.98 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.28 | ||
| Quick Ratio | 3.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
64.26
-0.46 (-0.71%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 10.34 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 22.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.94% | ||
| ROE | -40.15% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.73% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 34.04% | ||
| Cap/Sales | 2.61% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.28 | ||
| Quick Ratio | 3.12 | ||
| Altman-Z | 2.98 |
ChartMill assigns a fundamental rating of 3 / 10 to TEM.
ChartMill assigns a valuation rating of 1 / 10 to TEMPUS AI INC (TEM). This can be considered as Overvalued.
TEMPUS AI INC (TEM) has a profitability rating of 2 / 10.
The Earnings per Share (EPS) of TEMPUS AI INC (TEM) is expected to grow by 75.39% in the next year.